Protagenic Therapeutics (PTIX) Short Interest Ratio & Short Volume $0.70 -0.03 (-4.10%) (As of 07/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Protagenic Therapeutics Short Interest DataCurrent Short Interest10,400 sharesPrevious Short Interest10,100 sharesChange Vs. Previous Month+2.97%Dollar Volume Sold Short$7,800.00Short Interest Ratio0.7 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares4,450,000 sharesFloat Size3,480,000 sharesShort Percent of Float0.30%Today's Trading Volume5,469 sharesAverage Trading Volume6,530 sharesToday's Volume Vs. Average84% Short Selling Protagenic Therapeutics ? Sign up to receive the latest short interest report for Protagenic Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPTIX Short Interest Over TimePTIX Days to Cover Over TimePTIX Percentage of Float Shorted Over Time Ad American Hartford Gold GroupPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE Protagenic Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202410,400 shares $7,800.00 +3.0%0.3%0.7 $0.75 6/30/202410,100 shares $9,140.50 +11.0%0.3%0.7 $0.91 6/15/20249,100 shares $9,373.00 -37.7%0.3%0.6 $1.03 5/31/202414,600 shares $19,272.00 +50.5%0.4%1 $1.32 5/15/20249,700 shares $12,901.00 +5.4%0.3%0.6 $1.33 4/30/20249,200 shares $12,666.56 -6.1%0.3%0.8 $1.38 Get the Latest News and Ratings for PTIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protagenic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/15/20249,800 shares $13,693.54 -13.3%0.3%0.9 $1.40 3/31/202411,300 shares $19,775.00 -7.4%0.3%1.1 $1.75 3/15/202412,200 shares $14,030.00 +32.6%0.3%1.3 $1.15 2/29/20249,200 shares $9,660.00 -6.1%0.3%1.1 $1.05 2/15/20249,800 shares $9,457.00 -31.0%0.3%1.4 $0.97 1/31/202414,200 shares $13,490.00 No Change0.4%2.4 $0.95 11/15/20239,200 shares $7,866.00 -6.1%0.3%0.7 $0.86 10/31/20239,800 shares $7,614.60 +988.9%0.3%0.7 $0.78 10/15/2023900 shares $755.10 -81.6%0.0%0.1 $0.84 9/30/20234,900 shares $9,016.00 +69.0%0.1%0.4 $1.84 9/15/20232,900 shares $5,046.00 +107.1%0.1%0.7 $1.74 8/31/20231,400 shares $2,660.00 +16.7%0.0%0.4 $1.90 2/12/2021100 shares $414.00 No ChangeN/A1 $4.14 1/29/2021100 shares $415.00 No ChangeN/A0.1 $4.15 9/30/2020100 shares $122.00 No ChangeN/A1 $1.22 9/15/2020100 shares $117.00 No ChangeN/A1 $1.17 8/31/2020100 shares $117.00 No ChangeN/A1 $1.17 8/14/2020100 shares $117.00 No ChangeN/A1 $1.17 7/31/2020100 shares $117.00 No ChangeN/A1 $1.17 7/15/2020100 shares $117.00 No ChangeN/A1 $1.17 6/30/2020100 shares $117.00 No ChangeN/A1 $1.17 6/15/2020100 shares $115.00 No ChangeN/A1 $1.15 5/29/2020100 shares $125.00 No ChangeN/A1 $1.25 5/15/2020100 shares $125.00 No ChangeN/A1 $1.25 4/30/2020100 shares $125.00 No ChangeN/A1 $1.25 4/15/2020100 shares $125.00 No ChangeN/A1 $1.25 3/31/2020100 shares $116.00 No ChangeN/A0.5 $1.16 3/13/2020100 shares $162.00 No ChangeN/A1 $1.62 2/28/2020100 shares $141.01 No ChangeN/A1 $1.41 2/14/2020100 shares $141.01 No ChangeN/A1 $1.41 1/31/2020100 shares $141.01 No ChangeN/A1 $1.41 1/15/2020100 shares $141.01 No ChangeN/A1 $1.41 12/31/2019100 shares $380.00 No ChangeN/A1 $3.80 PTIX Short Interest - Frequently Asked Questions What is Protagenic Therapeutics' current short interest? Short interest is the volume of Protagenic Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 10,400 shares of PTIX short. 0.30% of Protagenic Therapeutics' shares are currently sold short. Learn More on Protagenic Therapeutics' current short interest. What is a good short interest ratio for Protagenic Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PTIX shares currently have a short interest ratio of 1.0. Learn More on Protagenic Therapeutics's short interest ratio. What is a good short interest percentage for Protagenic Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.30% of Protagenic Therapeutics' floating shares are currently sold short. Is Protagenic Therapeutics' short interest increasing or decreasing? Protagenic Therapeutics saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 10,400 shares, an increase of 3.0% from the previous total of 10,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Protagenic Therapeutics' float size? Protagenic Therapeutics currently has issued a total of 4,450,000 shares. Some of Protagenic Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Protagenic Therapeutics currently has a public float of 3,480,000 shares. How does Protagenic Therapeutics' short interest compare to its competitors? 0.30% of Protagenic Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Protagenic Therapeutics: Kiora Pharmaceuticals, Inc. (0.67%), Imunon, Inc. (2.99%), Cardio Diagnostics Holdings, Inc. (1.57%), Eterna Therapeutics Inc. (1.84%), PHAXIAM Therapeutics S.A. (0.01%), RedHill Biopharma Ltd. (1.07%), Tonix Pharmaceuticals Holding Corp. (2.46%), Kineta, Inc. (2.18%), Alterity Therapeutics Limited (0.21%), Shuttle Pharmaceuticals Holdings, Inc. (0.80%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short Protagenic Therapeutics stock? Short selling PTIX is an investing strategy that aims to generate trading profit from Protagenic Therapeutics as its price is falling. PTIX shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Protagenic Therapeutics? A short squeeze for Protagenic Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PTIX, which in turn drives the price of the stock up even further. How often is Protagenic Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PTIX, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies: KPRX Short Squeeze IMNN Short Squeeze CDIO Short Squeeze ERNA Short Squeeze PHXM Short Squeeze RDHL Short Squeeze TNXP Short Squeeze KA Short Squeeze ATHE Short Squeeze SHPH Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PTIX) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protagenic Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protagenic Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.